Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series.

Authors	Alexander Ten Hagen, Elisa Habermann, Sandra Hermann, Gerd R Burmester, Robert Biesen, Fredrik N Albach
Journal	RMD open (RMD Open) Vol. 8 Issue 2 (12 2022) ISSN: 2056-5933 [Electronic] England
PMID	36597976 (Publication Type: Letter)
Chemical References	Rituximab
Topics	Humans Rituximab (adverse effects) Antibody Formation COVID-19 (prevention & control) Vaccination (adverse effects) Rheumatic Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!